CYT013-IL1bQb

· Cytos Biotechnology AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CYT013-IL1bQb, covering 2012-02-13 to 2012-02-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes [Phase 1]